---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-25-098755"
form_type: "8-K"
ticker: "SSKN"
cik: "0001051514"
company_name: "STRATA Skin Sciences, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:50:32.452966+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Strata Skin Sciences gains Nasdaq extension to Feb. 16, 2026 for equity compliance

## Summary
- Nasdaq accepted Strata's plan and extended the deadline to Feb. 16, 2026 to meet the $2.5M stockholders' equity requirement.
- Company originally received a deficiency notice on Aug. 22, 2025 and submitted a compliance plan on Sept. 19, 2025.
- Strata is evaluating options to regain compliance, but cautions there is no guarantee of success; non-compliance by the deadline could lead to delisting.

## SEC filing metadata
- accession: 0001213900-25-098755
- form_type: 8-K
- ticker: SSKN
- cik: 0001051514
- company_name: STRATA Skin Sciences, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1051514/000121390025098755/0001213900-25-098755-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1051514/000121390025098755/ea0261071-8k_strata.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-25-098755
- JSON: https://secwatch.observer/filing/0001213900-25-098755.json
- Plain text: https://secwatch.observer/filing/0001213900-25-098755.txt

## Source-grounded claims
- claim_id: a45a814b72030cdacf5c8e6814bf051283e6d114
  claim: STRATA Skin Sciences, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: August 22, 2025, Strata Skin Sciences, Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). On September 19, 2025, the Company submitted a plan to Nasdaq to regain compliance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000121390025098755/0001213900-25-098755-index.htm
- claim_id: a7f69d9370a0e5aaa1ec55bbbd500f37f9ecd471
  claim: STRATA Skin Sciences, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).
  evidence_excerpt: August 22, 2025, Strata Skin Sciences, Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). On September 19, 2025, the Company submitted a plan to Nasdaq to regain compliance
  evidence_url: https://www.sec.gov/Archives/edgar/data/1051514/000121390025098755/0001213900-25-098755-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.